Clopidogrel bisulfate tablet formulation

Details Clopidogrel bisulfate tablet formulation Clopidogrel bisulfate tablet formulation

2005-07-05

2005-07-05

Qazi, Sabiha N. (Department: 1616)

Organic compounds -- part of the class 532-570 series

Organic compounds

Heterocyclic carbon compounds containing a hetero ring...

C514S039000, C514S301000, C424S408000, C424S464000, C424S468000, C424S474000

Reexamination Certificate

active

06914141

ABSTRACT:
Pharmaceutical tablets comprising clopidogrel bisulfate and a lubricant selected from zinc stearate, stearic acid, and sodium stearyl fumarate.

REFERENCES:
patent: 4847265 (1989-07-01), Badorc et al.
patent: 6210712 (2001-04-01), Edgren et al.
patent: 6504030 (2003-01-01), Bousquet et al.
patent: 6635763 (2003-10-01), Pandey et al.
patent: 6737411 (2004-05-01), Valeriano et al.
patent: 6737419 (2004-05-01), Sherman
patent: 6767913 (2004-07-01), Lifshitz et al.
patent: 6800759 (2004-10-01), Valeriano et al.
Abstract of WO 9961026 A1 (Batra et al), AN: 1999:763873 HCAPLUS, DN: 132:15626.

Affiliated with

Also associated with

Rating

Clopidogrel bisulfate tablet formulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Clopidogrel bisulfate tablet formulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Clopidogrel bisulfate tablet formulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3415629